FDA Warns Savannah Chrisley Over Misleading Claims on Weight Loss Medicine Website

Reality star's GoodGirlRX site cited for unapproved drug product claims

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

The U.S. Food and Drug Administration (FDA) has issued a warning letter to Savannah Chrisley, the reality TV star, over misleading claims on her GoodGirlRX website regarding the approval and effectiveness of weight-loss medications. The agency stated that the compounded drug products offered are not FDA-approved and gave Chrisley 15 business days to correct the violations, which she has since done by adding disclaimers and changing wording on the site.

Why it matters

This case highlights the FDA's strict oversight of health and medical claims, especially around unapproved or misleading marketing of pharmaceutical products. As the daughter of Todd and Julie Chrisley, who recently served federal prison sentences for bank and tax fraud, Savannah Chrisley is under heightened scrutiny for any potential legal issues with her business ventures.

The details

The FDA took issue with Chrisley's use of phrases such as "FDA-approved meds," "FDA-approved options," and "clinically proven GLP-1 results" on the GoodGirlRX website. The agency reminded Chrisley that compounded drug products, like the ones offered, are not FDA-approved and that claims about their safety and effectiveness were misleading. Chrisley was given 15 business days to make corrections, which she has since done by adding disclaimers and changing wording on the site.

  • The FDA issued the warning letter to Savannah Chrisley last month.
  • Chrisley was given 15 business days to make corrections to the website.

The players

Savannah Chrisley

Reality TV star and founder of the wellness company GoodGirlRX.

U.S. Food and Drug Administration (FDA)

The federal agency responsible for protecting public health by regulating food, drugs, and other products.

Todd and Julie Chrisley

Savannah Chrisley's parents, who recently served federal prison sentences for bank and tax fraud.

Got photos? Submit your photos here. ›

What they’re saying

“This was about website wording, not patient safety. There were no fines and no disciplinary action. We're proud to help women access licensed physicians and we welcome the FDA's guidance.”

— Savannah Chrisley (TMZ)

The takeaway

This case highlights the importance of making truthful and accurate claims when marketing health and medical products, especially those involving pharmaceuticals. The FDA closely monitors such claims to protect consumers from misleading information, and businesses must be diligent in ensuring their marketing materials comply with federal regulations.